• 제목/요약/키워드: carrier transport mechanism

검색결과 64건 처리시간 0.025초

유기 음이온계 약물의 간수송과정에 있어서 대향수송현상에 관한 속도론적 연구 (Kinetic Analysis of the Counter-transport Phenomenon in the Hepatic Transport of Organic Anionic Drugs)

  • 정연복;한건;노정렬
    • Journal of Pharmaceutical Investigation
    • /
    • 제22권4호
    • /
    • pp.289-300
    • /
    • 1992
  • The counter-transport phenomena in the hepatic transport of 1-anilino-8-naphthalene sulfonate (ANS) were kinetically investigated by analyzing the plasma disappearance-time profiles and the transport into the isolated hepatocytes. In vivo "counter transport phenomena" were simulated based on the perfusion model which incorporated the carrier-mediated transport and the saturable intracellular binding. The condition that the mobility of carrier-ligand complex is greater than that of free carrier is not essential for the occurrence of counter-transport phenomenon. To examine the inhibitory effects on the initial uptake of a ligand by the liver, it is necessary to judge whether the true counter-transport mechanism (trans-stimulation) is working or not. The initial plasma disappearance curves of ANS were then kinetically analyzed based on a two-compartment model, in which the ligand is eliminated only from the peripheral compartment (liver compartment). No effects on the initial plasma disappearance rates of ANS were observed after preloading of bromophenol blue (BPB) or rose bengal (RB) in the liver. Inhibitory effect of BPB or RB on the initial uptake (or efflux) rates of ANS by the isolated hepatocytes were not observed, suggesting that the true counter transport mechanism is not working. In conclusion, checking the preloading effects of transstimulation on the initial uptake of a ligand by the liver could be a useful criterion for carrier cycling and common use of the same carrier between two ligands. However, one cannot exclude those possibilities even if the preloading effects cannot be observed.

  • PDF

음이온계 약물의 간수송과정에 있어서 담체매개 수송의 약물동력학적 모델링 및 시뮬레이션 (Pharmacokinetic Modeling and Simulation of the Carrier-Mediated Hepatic Transport of Organic Anions)

  • 이준섭;강민희;김묘경;이명구;정석재;심창구;정연복
    • 약학회지
    • /
    • 제47권2호
    • /
    • pp.110-119
    • /
    • 2003
  • The purpose of the present study was to kinetically investigate the carrier-mediated uptake in the hepatic transport of organic anions, and to simulate the ″in vivo counter-transport″ phenomena, using kinetic model which was developed in this study. The condition that the mobility of carrier-ligand complex is greater than that of free carrier is not essential for the occurrence of ″counter-transport″ phenomenon. To examine the inhibitory effects on the initial uptake of a ligand by the liver, it is necessary to judge whether the true counter-transport mechanism (trans-stimulation) is working or not. The initial plasma disappearance curves of a organic anion were then kinetically analyzed based on a flow model, in which the ligand is eliminated only from the peripheral compartment (liver compartment). Moreover, ″in vive counter-transport″ phenomena were simulated based on the perfusion model which incorporated the carrier-mediated transport and the saturable intracellular binding. The ″in vivo counter-transport″ phenomena in the hepatic transport of a organic anion were well demonstrated by incorporating the carrier-mediated process. However, the ″in vivo counter-transport″ phenomena may be also explained by the enhancement of back diffusion due to the displacement of intracellular binding. In conclusion, one should be more cautious in interpreting data obtained from so-called ″in vivo counter-transport″ experiments.

Cholestric 액정 Cholesteryl Benzoate에서 Drift Mobility측정 (Electrical Drift Mobility in the Cholesteryl Benzoate)

  • 강태원;김화택
    • 대한전자공학회논문지
    • /
    • 제15권2호
    • /
    • pp.19-21
    • /
    • 1978
  • Cholesteryl Benzoate 액정에서 전류 수송기구를 규명하기 위하여 charge carrier의 어i도 mobilits를 극성 반전법을 사용하여 140∼185℃의 온도 영 역에서 측정했다. charge carrier의 drift mobilits는 주위온도가 증가함에 따라 2.5×10-7㎠/V.sec에서 2.0×10-6㎠/V.sec까지 증가했다. 이 실험결과로 부터 전류 수송기구는 ionic기구로 설명할 수 있다.

  • PDF

납 중독 랫드의 말초신경내 myo-inositol 수송 체계에 관한 연구 (A study on myo-inositol transport system in peripheral nerve isolated from lead-intoxicated rat.)

  • 정명규;조해용
    • 환경위생공학
    • /
    • 제11권2호
    • /
    • pp.21-26
    • /
    • 1996
  • In our previous studies, we reported that lead intoxicated nerve cell by inhibition of the Na$^{+}$-K$^{+}$ ATPase activity and reduction of myo-inositol in nerve cell. As the second series of experiments, in order to understand toxic mechanism of lead for nerve cell, the characteristics of myo-inositol transport system and the effect of lead on its system have been studied in the sciatic nerves of control and lead-treated rats. A lead intoxicated animal model was induced by feeding diet containing lead to Sprague-Dawley rat for two weeks. Four weeks aged Sprague-Dawley rats were divided into three group : normal control group, 10ppm-lead treated group, 100ppm-lead treated group. All rats were sacrified at the end of two weeks. The rate o myo-inositol transport by sciatic nerve isolated from lead-treated rat was significantly decreased compared with that of control rat. This deficit results from that myo-inositol transport system which is carrier mediated and sodium-potassium dependent was inhibited by the lead treatment (both 10ppm and 100ppm) due to increase of the Km value without affecting Vmax value for myo-inositol carrier. These observations suggest that the toxic mechanism of lead on nerve myo-inositol transport system might be a change of affinity without change of maximum transport velocity for carrier.

  • PDF

염기성 및 산성 약물의 혈액-뇌관문 투과에 관여하는 내인적 수송계 (Role of Endogenous Transport Systems for the Transport of Basic and Acidic Drugs at Blood-Brain Barrier)

  • 강영숙
    • Journal of Pharmaceutical Investigation
    • /
    • 제23권1호
    • /
    • pp.1-9
    • /
    • 1993
  • The endothelial cell of brain capillary called the blood-brain barrier (BBB) has carrier-mediated transport systems for nutrients and drugs. The mechanism of the BBB transport of basic and acidic drugs has been reviewed and examined for endogenous transport systems in BBB in WKY and SHRSP. Acidic drugs such as salicylic acid and basic drugs such as eperisone are taken up in a carrier mediated manner through the BBB via the monocarboxylic acid and amine transport systems. The specific dysfunction for the choline transport at the BBB in SHRSP would affect the function of the brain endothelial cell and brain parenchymal cell. The utilization of the endogenous transport systems of monocarboxylic acid and amine could be promising strategy for the effective drug delivery to the brain.

  • PDF

Characterization of Absorption Process of Taurine Across Rat Small Intestine

  • Kim, Kyung-Soon
    • Archives of Pharmacal Research
    • /
    • 제6권2호
    • /
    • pp.109-114
    • /
    • 1983
  • A mechanism of taurine transfer across the rat small intestine was elucidated by using the in situ recirculation perfusion or loop method. Taurine uptake was saturable, Km= 39.9 mM, and energy dependent, and required sodium. The close structural analogues, aminomethane sulfonic acid, .gamma.-amino-butyric acid, hypotaurine, and .betha.-alanine, reduced significantly taurine uptake when present in 10-fold excess. The .alpha.-amino acid, glycine, did not inhibit uptake. Hence, all of these findings lead to a conclusion that a carrier-mediated transport system for taurine exists in the small intestine.

  • PDF

SCH 양자우물 레이저 다이오드의 수송기구와 변조응답 특성에 관한 연구 (A Study on the Transport Mechanism of a SCH Quantum-Well Laser Diode and on the Modulation Characteristics)

  • 김종기;정재용;서정하
    • 대한전자공학회논문지TE
    • /
    • 제37권1호
    • /
    • pp.27-34
    • /
    • 2000
  • 본 논문에서는 SCH 양자우물 구조를 가진 레이저 다이오드에서의 캐리어 수송기구와 변조응답 특성에 대해 고찰하였다. 캐리어 수송구조 고찰을 위해 캐리어 밀도분포및 다이오드전류를 계산하였다. 또한 우물내에서의 캐리어 재결합율을 SCH길이의 함수로 도출하였다. 변조응답 특성에서는 캐리어와 광자에 대한 3쌍의 비율 방정식을 도출, 해석하여 SCH 길이에 따른 변조 대역폭과 완화 진동 주파수, 감쇄 비율과 K-factor의 특성에 대하여 고찰하였다.

  • PDF

음이온계 약물의 간수송과정에 있어서 대향수송의 약물동력학적 모델링 및 시뮬레이션 (Pharmacokinetic Modelling and Simulation of the Counter-transport in the Hepatic Transport of Organic Anions)

  • 송석길;이준섭;정연복
    • 약학회지
    • /
    • 제49권4호
    • /
    • pp.275-283
    • /
    • 2005
  • The purpose of the present study was to kinetically investigate the carrier-mediated uptake in the hepatic transport of organic anions, and to simulate the 'in vivo counter-transport' phenomena, using kinetic model which was developed in this study. The condition that the mobility of carrier-ligand complex is greater than that of free carrier is not essential for the occurrence of 'counter-transport' phenomenon. To examine the inhibitory effects on the initial uptake of organic anions by the liver, it is necessary to judge whether the true counter-transport mechanism (trans-stimulation) is working or not. Effects of bromophenol blue (BPB) or bromosulfophthalein (BSP) on the plasma disappearance curves of a 1-anilino-8-naphthalene sulfonate (ANS) were then kinetically analyzed based on a flow model, in which the ligand is eliminated only from the peripheral compartment (liver compartment). Moreover, 'in vivo counter-transport' phenomena were simulated based on the perfusion model which incorporated the carrier-mediated transport and the saturable intracellular binding. The 'in vivo counter-transport' phenomena in the hepatic transport of a organic anions were well demonstrated by incorporating the carrier-mediated process. However, the 'in vivo counter-transport' phenomena may be also explained by the enhancement of back diffusion due to the displacement of intracellular binding. In conclusion, one should be more cautious in interpreting data obtained from so-called 'in vivo counter-transport' experiments.

Silver Polymer Electrolyte Membranes for Facilitated Olefin Transport: Carrier Properties, Transport Mechanism and Separation Performance

  • Kim, Jong-Hak;Kang, Yong-Soo
    • Macromolecular Research
    • /
    • 제12권2호
    • /
    • pp.145-155
    • /
    • 2004
  • Facilitated transport membranes for the separation of olefin/paraffin mixtures have long been of interest in separation membrane science because olefins, such as propylene and ethylene, which are important chemicals in petrochemical industries, are currently separated by energy-intensive cryogenic distillation processes. Recently, solid polymer electrolyte membranes containing silver ions have demonstrated remarkable performance in the separation of olefin/paraffin mixtures in the solid state and, thus, they can be considered as alternatives to cryogenic distillation. Here, we review recent progress, and critical issues affecting in the use of facilitated olefin transport membranes; in particular, we provide a general overview with reference to carrier properties, transport mechanisms, and separation performance.

흰쥐의 비강과 공장에서의 세픽심의 흡수기전 (Absorption Mechanism of Cefixime through the Nasal Cavity and Jejunum in Rats)

  • 박기배;노현구;이광표
    • 약학회지
    • /
    • 제38권2호
    • /
    • pp.114-122
    • /
    • 1994
  • A study on the absorption mechanism of cefixime(CF), an oral ${\alpha}-amino$ group deficient cephalosporin antibiotic, has been undertaken through the rat jejunum and nasal cavity using an in situ simultaneous perfusion technique developed in our laboratory. CF was well absorbed in the jejunum and nasal cavity of rats at pH 5.0, but not at pH 7.0. CF absorption was studied over four orders of magnitude in concentration to determine saturability. Disappearance of CF in the perfusate followed first-order kinetics at all tested concentrations. The apparent first-order absorption rate constant was found to be dependent on the concentration over the range of $0.1\;mM{\sim}3\;mM$ in the jejunum and nasal cavity of rats. Inhibitors were added to determine the competitive inhibition of CF absorption. The presence of L-tyrosine, L-phenylalanine, alanine-alanine, glycine-glycine and cefadroxil produced the significant inhibition of CF absorption in the nasal cavity and jejunum. However, there was no evidence of the inhibition in the presence of cefazolin. In addition, The CF absorption in the nasal cavity and jejunum was inhibited significantly by ouabain and 2,4-dinitrophenol(DNP). This study suggested that CF is absorbed across the rat nasal cavity and jejunum by carrier-mediated transport mechanism and energy consuming system.

  • PDF